Download Narcolepsy (HLA-DQB1) Genotyping - Lab Test Directory

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Behavioural genetics wikipedia , lookup

Inbreeding wikipedia , lookup

Epistasis wikipedia , lookup

Public health genomics wikipedia , lookup

Genome (book) wikipedia , lookup

Designer baby wikipedia , lookup

Cell-free fetal DNA wikipedia , lookup

Human genetic variation wikipedia , lookup

SNP genotyping wikipedia , lookup

Genetic testing wikipedia , lookup

Hardy–Weinberg principle wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Medical genetics wikipedia , lookup

Population genetics wikipedia , lookup

Microevolution wikipedia , lookup

Dominance (genetics) wikipedia , lookup

Genetic drift wikipedia , lookup

Transcript
Narcolepsy (HLA-DQB1) Genotyping
Indications for Ordering
Genetics
Aids in clinical diagnosis of narcolepsy
Gene – HLA-DQB1
Test Description
Polymerase chain reaction (PCR) with melting-curve analysis
to detect the HLA-DQB1*06:02 allele
Mutation – HLA-DQB1*06:02
• Cause of narcolepsy is multifactorial
o Both genetic and environmental components
• Familial cases are rare
Tests to Consider
Test Interpretation
Evaluation to rule out other treatable disorders may include
• CBC with Platelet Count and Automated Differential
0040003
• Glucose, Plasma or Serum 0020024
• Drugs of Abuse 9 Panel, Urine – Screen Only 0090453
• Drug Screen (Nonforensic), Urine, Qualitative 0090500
• Melatonin 0098816
Sensitivity/specificity
• Clinical sensitivity – 85-95%
• Clinical specificity – <1%
• Analytical sensitivity/specificity – 99%
Genetic testing
• Narcolepsy (HLA-DQB1*06:02) Genotyping 2005023
Disease Overview
Prevalence – 1/2,000 affected with narcolepsy
Incidence
• HLA-DQB1*06:02 allele
o Varies by ethnicity
o Caucasians
 15% of general population has HLA-DQB1*06:02 allele
 99% with narcolepsy and cataplexy have HLADQB1*06:02 allele
o Also strongly associated with narcolepsy in other
populations (Japanese, African Americans, Koreans,
Hispanics)
Results
• Positive
o HLA-DQB1*06:02 allele detected
 Supportive of a clinical diagnosis of narcolepsy
 Does not by itself establish a diagnosis
• Negative
o HLA-DQB1*06:02 allele not detected
 Diagnosis of narcolepsy is less likely but not eliminated
Limitations
• Does not differentiate between heterozygosity and
homozygosity of the HLA-DQB1*06:02 allele
• Rare diagnostic errors may occur due to primer-site
mutations
• Alleles other than HLA-DQB1*06:02 will not be identified
• Other genetic and nongenetic factors that influence
narcolepsy are not evaluated
Age of onset
• Narcolepsy is generally diagnosed in adulthood
• Has been reported in children
Symptoms
• Narcolepsy is a sleep disorder
o Excessive daytime sleepiness
o Cataplexy
 Sudden loss of muscle tone triggered by strong
emotions
o Disturbed nighttime sleep
o Sleep paralysis
o Hypnagogic hallucinations
 Occurs in the period between sleep and wakefulness
• Diagnosis based on clinical symptoms
JUNE 2015 | © 2013 ARUP LABORATORIES | ARUP is a nonprofit enterprise of the University of Utah and its Department of Pathology.
500 Chipeta Way, Salt Lake City, UT 84108 | (800) 522-2787 | (801) 583-2787 | www.aruplab.com | www.arupconsult.com